Literature DB >> 2404560

Transvaginal sonography as a screening method for ovarian cancer. A report of the first 1000 cases screened.

J R van Nagell1, R V Higgins, E S Donaldson, H H Gallion, D E Powell, E J Pavlik, C H Woods, E A Thompson.   

Abstract

From November 1987 to April 1989, 1000 women 40 years or older underwent screening vaginal sonography at the University of Kentucky Medical Center (Lexington, KY). Patients included in this investigation were all asymptomatic and had no known pelvic abnormalities. Each ovary was measured in three planes and ovarian volume was calculated using the prolate ellipsoid formula. The upper limit of normal for ovarian volume was 18 cm3 in premenopausal women and 8 cm3 in postmenopausal women. In patients with normal scans, mean ovarian volumes decreased from 6.8 cm3 to 3.0 cm3 with menopause. Thirty-one patients (3.1%) had abnormal vaginal sonograms and 24 underwent exploratory laparotomy. All patients undergoing surgery had ovarian or fallopian tube tumors with dimensions identical to those predicted by ultrasound. Histologic diagnoses of these tumors included the following: adenocarcinoma, one, serous cystadenoma, eight; endometrioma, six; and cystic teratomas, two. Vaginal sonography was performed easily and without complications, and was well accepted by patients. All patients with normal sonograms have been rescreened annually and none have subsequently developed ovarian cancer. Further clinical trials to determine the efficacy of vaginal sonography as a screening method for ovarian cancer are indicated.

Entities:  

Mesh:

Year:  1990        PMID: 2404560     DOI: 10.1002/1097-0142(19900201)65:3<573::aid-cncr2820650331>3.0.co;2-4

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography.

Authors:  I Jacobs; A P Davies; J Bridges; I Stabile; T Fay; A Lower; J G Grudzinskas; D Oram
Journal:  BMJ       Date:  1993-04-17

2.  Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging.

Authors:  T H Bourne; S Campbell; K M Reynolds; M I Whitehead; J Hampson; P Royston; T J Crayford; W P Collins
Journal:  BMJ       Date:  1993-04-17

3.  Diagnosis-shift between low-grade serous ovarian cancer and serous borderline ovarian tumor: A population-based study.

Authors:  Koji Matsuo; Hiroko Machida; Brendan H Grubbs; Shinya Matsuzaki; Maximilian Klar; Lynda D Roman; Anil K Sood; David M Gershenson
Journal:  Gynecol Oncol       Date:  2020-01-15       Impact factor: 5.482

4.  CA19-9 elevation in ovarian mature cystic teratoma: discrimination from ovarian cancer - CA19-9 level in teratoma.

Authors:  Hye-yon Cho; Kidong Kim; Yong-Tark Jeon; Yong-Beom Kim; Jae Hong No
Journal:  Med Sci Monit       Date:  2013-03-29

5.  Survival of Women With Type I and II Epithelial Ovarian Cancer Detected by Ultrasound Screening.

Authors:  John R van Nagell; Brian T Burgess; Rachel W Miller; Lauren Baldwin; Christopher P DeSimone; Frederick R Ueland; Bin Huang; Quan Chen; Richard J Kryscio; Edward J Pavlik
Journal:  Obstet Gynecol       Date:  2018-11       Impact factor: 7.623

Review 6.  Early detection of ovarian cancer: background, rationale, and structure of the Yale Early Detection Program.

Authors:  P E Schwartz; J T Chambers; K J Taylor; J Pellerito; L Hammers; L A Cole; T L Yang-Feng; P Smith; S T Mayne; R Makuch
Journal:  Yale J Biol Med       Date:  1991 Nov-Dec

Review 7.  Screening and Prevention for High-Grade Serous Carcinoma of the Ovary Based on Carcinogenesis-Fallopian Tube- and Ovarian-Derived Tumors and Incessant Retrograde Bleeding.

Authors:  Isao Otsuka; Takuto Matsuura
Journal:  Diagnostics (Basel)       Date:  2020-02-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.